CMP : 788
Target Price : 877
For 1QFY2017, the company’s sales came in at Rs3,664cr V/s Rs3,900cr
expected and V/s Rs3,664cr in 1QFY2017, a yoy growth of 13.0%, mainly
driven by formulations. Formulations (Rs3,032cr) posted a yoy growth of
15.9% and constituted around 80% of overall sales, while API (Rs735cr)
posted a yoy growth of 1.6%. On the operating front, the E..